Filter
565
Text search:
drug
financing
Featured
Recommendations
36
New Publications
164
Language
Document type
No document type
359
Studies & Reports
97
Guidelines
39
Strategic & Response Plan
37
Manuals
17
Situation Updates
6
Fact sheets
4
Training Material
3
Infographics
2
Resource Platforms
1
Countries / Regions
Global
30
Kenya
23
Ethiopia
19
Western and Central Europe
19
Ghana
16
Uganda
16
Malawi
16
Zambia
15
Eastern Europe
15
Sierra Leone
14
India
14
Rwanda
13
Nigeria
12
Nepal
12
South Africa
12
Liberia
10
Tanzania
9
Latin America and the Carribbean
9
Asia
8
Africa
8
Philippines
7
Ukraine
7
Myanmar / Burma
7
Senegal
6
South–East Asia Region
6
Zimbabwe
5
Cambodia
5
Bangladesh
5
East and Southern Africa
5
Namibia
4
Russia
4
Cameroon
3
Syria
3
Botswana
3
Lesotho
3
West and Central Africa
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Congo, Democratic Republic of
2
South Sudan
2
Venezuela
2
Tajikistan
2
Moldova
2
Georgia
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Afghanistan
1
Germany
1
Turkey
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Eswatini/ Swaziland
1
Bolivia
1
Western Pacific Region
1
Albania
1
Armenia
1
Timor Leste/ East Timor
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
255
Public Health
35
Clinical Guidelines
27
Key Resources
19
Women & Child Health
16
Pharmacy & Technologies
6
Capacity Building
3
Toolboxes
HIV
77
TB
75
COVID-19
27
Mental Health
24
AMR
22
Pharmacy
15
Health Financing Toolbox
13
Planetary Health
12
Conflict
8
Global Health Education
8
Caregiver
7
NTDs
7
Ebola & Marburg
4
NCDs
4
Rapid Response
3
Refugee
3
Malaria
3
Disability
2
Polio
2
Natural Hazards
2
Social Ethics
2
Cholera
1
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards transforming and improving public health services in t
...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
Recommendations for a Public Health approach and considerations for policy-makers and managers
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
This guide is an attempt to redress the deficit in understanding of implementation research and to encourage programme personnel and implementers to take a greater interest in the subject, recognizing that implementation research is in fact an integral part of programme planning and execution, rathe
...
This is one of seven Medical Peace Work courses.
Bulletin of the World Health Organization 2007;85:637–643
Une traduction en français de ce résumé figure à la fin de l’article.
Al final del artículo se facilita una traducción al español.
الترجمة العربية لهذه الخلاصة في نهاية النص الكامل ل
...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care,
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
The End TB Strategie
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which
...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The
...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting
...
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and morbidity in urban poor settings today requires an expansion of effective Maternal and Newborn Health (MNH) care services and lowering the barrier
...
